Pub Date : 2024-08-15eCollection Date: 2024-01-01DOI: 10.2337/dsi24-0008
Amanda L Olinger, Shilpa Sachdeva, Ann M Manzardo, Sharon E Cain
Individuals with diabetes are at increased risk for psychological, behavioral, and social problems. Comorbid mental illness and diabetes present a unique set of challenges for people with diabetes and their health care providers, particularly in an inpatient setting. Psychiatric symptoms before admission may affect type 1 diabetes management, and mental status and behavior can affect individuals' ability to cooperate with treatment while they are inpatients. This article describes a clinical protocol to manage type 1 diabetes and maximize patient safety in an acute inpatient child psychiatric unit.
{"title":"Managing Type 1 Diabetes in an Inpatient Child Psychiatric Care Setting.","authors":"Amanda L Olinger, Shilpa Sachdeva, Ann M Manzardo, Sharon E Cain","doi":"10.2337/dsi24-0008","DOIUrl":"10.2337/dsi24-0008","url":null,"abstract":"<p><p>Individuals with diabetes are at increased risk for psychological, behavioral, and social problems. Comorbid mental illness and diabetes present a unique set of challenges for people with diabetes and their health care providers, particularly in an inpatient setting. Psychiatric symptoms before admission may affect type 1 diabetes management, and mental status and behavior can affect individuals' ability to cooperate with treatment while they are inpatients. This article describes a clinical protocol to manage type 1 diabetes and maximize patient safety in an acute inpatient child psychiatric unit.</p>","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"37 3","pages":"234-240"},"PeriodicalIF":0.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327167/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-15eCollection Date: 2024-01-01DOI: 10.2337/dsi24-0011
G Todd Alonso, Andrea Houk, Pamela Brunner Nii, Dianne Chorny, Kathleen Patrick, Leah Wyckoff
Since 2005, a group of stakeholders in Colorado has collaborated to improve diabetes management in schools and childcare centers by standardizing care and embedding local expertise to support school personnel in this task. This effort has included the development of toolkits for parents, school nurses, and other health care providers; the establishment of a diabetes resource nurses program; and annually updated guidelines titled Standards of Care for Diabetes Management in the School Setting & Licensed Child Care Facilities. This collaboration has fundamentally changed how school nurses and staff in Colorado care for students with diabetes.
{"title":"Standardizing Diabetes Care in Colorado Schools: Nearly Two Decades of Success.","authors":"G Todd Alonso, Andrea Houk, Pamela Brunner Nii, Dianne Chorny, Kathleen Patrick, Leah Wyckoff","doi":"10.2337/dsi24-0011","DOIUrl":"10.2337/dsi24-0011","url":null,"abstract":"<p><p>Since 2005, a group of stakeholders in Colorado has collaborated to improve diabetes management in schools and childcare centers by standardizing care and embedding local expertise to support school personnel in this task. This effort has included the development of toolkits for parents, school nurses, and other health care providers; the establishment of a diabetes resource nurses program; and annually updated guidelines titled <i>Standards of Care for Diabetes Management in the School Setting & Licensed Child Care Facilities</i>. This collaboration has fundamentally changed how school nurses and staff in Colorado care for students with diabetes.</p>","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"37 3","pages":"211-219"},"PeriodicalIF":0.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327171/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-15eCollection Date: 2024-01-01DOI: 10.2337/dsi24-0010
Lowell R Schmeltz, Nader Kasim
Attending summer camp can be a rewarding experience for children with type 1 diabetes and an opportunity for them to build their confidence and diabetes self-management skills. Diabetes camps are built to cater to the medical needs of children with diabetes. With proper communication, education, and resources, traditional summer camps can provide the same benefits.
{"title":"Diabetes Care at Summer Camps.","authors":"Lowell R Schmeltz, Nader Kasim","doi":"10.2337/dsi24-0010","DOIUrl":"10.2337/dsi24-0010","url":null,"abstract":"<p><p>Attending summer camp can be a rewarding experience for children with type 1 diabetes and an opportunity for them to build their confidence and diabetes self-management skills. Diabetes camps are built to cater to the medical needs of children with diabetes. With proper communication, education, and resources, traditional summer camps can provide the same benefits.</p>","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"37 3","pages":"220-226"},"PeriodicalIF":0.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327165/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-15eCollection Date: 2024-01-01DOI: 10.2337/dsi24-0013
Ryan J McDonough
{"title":"Diabetes in Diverse Settings.","authors":"Ryan J McDonough","doi":"10.2337/dsi24-0013","DOIUrl":"10.2337/dsi24-0013","url":null,"abstract":"","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"37 3","pages":"207-209"},"PeriodicalIF":0.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-15eCollection Date: 2024-01-01DOI: 10.2337/dsi24-0009
Jennifer L West, Rebecca A Ballard, John P May
Diabetes care within prison walls offers challenges and opportunities for both health care providers and individuals living with diabetes. To meet the challenges, providers and patients work together to manage diabetes within the limitations imposed by imprisonment. Upon release, patients face new challenges, as they transition from incarceration into the community.
{"title":"Considerations to Better Meet the Needs of People Living With Diabetes While in Prison or Detention.","authors":"Jennifer L West, Rebecca A Ballard, John P May","doi":"10.2337/dsi24-0009","DOIUrl":"10.2337/dsi24-0009","url":null,"abstract":"<p><p>Diabetes care within prison walls offers challenges and opportunities for both health care providers and individuals living with diabetes. To meet the challenges, providers and patients work together to manage diabetes within the limitations imposed by imprisonment. Upon release, patients face new challenges, as they transition from incarceration into the community.</p>","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"37 3","pages":"241-246"},"PeriodicalIF":0.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000988","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-15eCollection Date: 2024-01-01DOI: 10.2337/ds24-ge03
{"title":"About Ryan J. McDonough: Guest Editor.","authors":"","doi":"10.2337/ds24-ge03","DOIUrl":"10.2337/ds24-ge03","url":null,"abstract":"","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"37 3","pages":"210"},"PeriodicalIF":0.0,"publicationDate":"2024-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11327162/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142000987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Objective: This study aimed to assess the need for practice-wide quality improvement to support evidence-based type 2 diabetes screening for women with a history of gestational diabetes mellitus (GDM) receiving primary care. We sought to add the diagnosis of GDM to the problem list of women who did not have it at baseline.
Research design and methods: We identified all women in our practice with a history of GDM diagnosed between 2002 and 2023, quantified the proportion with GDM documented in their problem list, and examined patient- and clinician-level factors associated with having GDM appropriately documented at baseline.
Results: We identified 203 women with GDM receiving primary care within internal medicine. Of the 203 women, 73 (35.0%) did not have GDM documented in their problem list. Of those without GDM included on the problem list, 52% were overdue for type 2 diabetes screening compared with 41% of those with GDM documented before our intervention. We found race, parity, and previous abnormal glycemic laboratory test results to be highly predictive of whether the history of GDM was on patients' problem list. Upon completion of our intervention, we successfully achieved a 100% documentation rate for GDM diagnosis for women who previously lacked documentation in their problem list.
Conclusion: This work paves the way for targeted interventions aimed at improving care for women with a history of GDM, including delivery of interventions and education to prevent the onset of an appropriate clinical screening for type 2 diabetes.
{"title":"Improved Diabetes Screening for Women After Gestational Diabetes Mellitus.","authors":"Brittany Strelow, Justine Herndon, AnneMarie McMahon, Mark Takagi, Rozalina McCoy, Rachel Olson, Danielle O'Laughlin","doi":"10.2337/ds24-0005","DOIUrl":"10.2337/ds24-0005","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to assess the need for practice-wide quality improvement to support evidence-based type 2 diabetes screening for women with a history of gestational diabetes mellitus (GDM) receiving primary care. We sought to add the diagnosis of GDM to the problem list of women who did not have it at baseline.</p><p><strong>Research design and methods: </strong>We identified all women in our practice with a history of GDM diagnosed between 2002 and 2023, quantified the proportion with GDM documented in their problem list, and examined patient- and clinician-level factors associated with having GDM appropriately documented at baseline.</p><p><strong>Results: </strong>We identified 203 women with GDM receiving primary care within internal medicine. Of the 203 women, 73 (35.0%) did not have GDM documented in their problem list. Of those without GDM included on the problem list, 52% were overdue for type 2 diabetes screening compared with 41% of those with GDM documented before our intervention. We found race, parity, and previous abnormal glycemic laboratory test results to be highly predictive of whether the history of GDM was on patients' problem list. Upon completion of our intervention, we successfully achieved a 100% documentation rate for GDM diagnosis for women who previously lacked documentation in their problem list.</p><p><strong>Conclusion: </strong>This work paves the way for targeted interventions aimed at improving care for women with a history of GDM, including delivery of interventions and education to prevent the onset of an appropriate clinical screening for type 2 diabetes.</p>","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"38 1","pages":"33-40"},"PeriodicalIF":0.0,"publicationDate":"2024-08-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11825403/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143433072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-08-05eCollection Date: 2025-01-01DOI: 10.2337/ds23-0065
Youssef Ahmed Ali, Muhannad Sharara, Mostafa Mahrous, Abdelrahman Alaa Rezk, Ahmed Abuali, Mohamed Aly Seoudy, Mohamed Yousif Elnaghy, Ahmed Elsayed Elsekaily, Mohammed Elsayed Elkholy, Khaled Mohamed Ragab, Marwa Mohamed Badawy, Ibrahim Kamal, Ahmed Hashem Fathallah
{"title":"Maternal and Neonatal Efficacy and Safety Outcomes of Myo-Inositol in Women With or at High Risk of Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis.","authors":"Youssef Ahmed Ali, Muhannad Sharara, Mostafa Mahrous, Abdelrahman Alaa Rezk, Ahmed Abuali, Mohamed Aly Seoudy, Mohamed Yousif Elnaghy, Ahmed Elsayed Elsekaily, Mohammed Elsayed Elkholy, Khaled Mohamed Ragab, Marwa Mohamed Badawy, Ibrahim Kamal, Ahmed Hashem Fathallah","doi":"10.2337/ds23-0065","DOIUrl":"10.2337/ds23-0065","url":null,"abstract":"","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"38 1","pages":"82-92"},"PeriodicalIF":0.0,"publicationDate":"2024-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11825409/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143433932","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
David Von Nordheim, Cynthia Herrick, N. Verdecias, Rachel Garg, Matthew W Kreuter, Amy McQueen
Executive function (EF) impairment is associated with poorer outcomes for individuals with type 2 diabetes. Previous research has identified risk factors for EF impairment, but many of these are also associated with type 2 diabetes. To address this issue, this study identified relevant variables from the literature and compared their association with EF in a sample of people with type 2 diabetes. Adult members of a Medicaid health plan diagnosed with type 2 diabetes were enrolled in a social needs intervention trial. Using baseline data from the trial, bivariate and multivariable regression analyses examined associations between EF and demographic, health, and psychosocial factors. When controlling for other factors, we identified six significant correlates of EF impairment: age (β = 0.10), education (college vs. no college; β = −0.38), depression symptoms (β = 0.18), comorbidity burden (β = 0.21), diabetes-related distress (β = 0.14), and future time orientation (β = −0.13). Our analysis identified several factors associated with greater EF impairment, which may interfere with diabetes self-management. Providers should consider these factors when prescribing treatments and determine whether additional resources or accommodations are warranted.
执行功能(EF)受损与 2 型糖尿病患者较差的预后有关。以往的研究已经确定了导致执行功能受损的风险因素,但其中许多因素也与 2 型糖尿病有关。为了解决这个问题,本研究从文献中找出了相关变量,并在 2 型糖尿病患者样本中比较了这些变量与 EF 的关系。 医疗补助健康计划中被诊断出患有 2 型糖尿病的成人成员参加了一项社会需求干预试验。利用试验的基线数据,我们进行了双变量和多变量回归分析,研究了EF与人口、健康和社会心理因素之间的关系。 在控制其他因素的情况下,我们发现了六个与 EF 损伤显著相关的因素:年龄(β = 0.10)、教育程度(大学与非大学;β = -0.38)、抑郁症状(β = 0.18)、合并症负担(β = 0.21)、糖尿病相关困扰(β = 0.14)和未来时间取向(β = -0.13)。 我们的分析确定了与更大的 EF 损伤相关的几个因素,这些因素可能会干扰糖尿病的自我管理。医生在开具治疗处方时应考虑这些因素,并确定是否需要额外的资源或调整。
{"title":"Correlates of Self-Reported Executive Function Impairment Among Medicaid Beneficiaries With Type 2 Diabetes","authors":"David Von Nordheim, Cynthia Herrick, N. Verdecias, Rachel Garg, Matthew W Kreuter, Amy McQueen","doi":"10.2337/ds23-0067","DOIUrl":"https://doi.org/10.2337/ds23-0067","url":null,"abstract":"\u0000 \u0000 Executive function (EF) impairment is associated with poorer outcomes for individuals with type 2 diabetes. Previous research has identified risk factors for EF impairment, but many of these are also associated with type 2 diabetes. To address this issue, this study identified relevant variables from the literature and compared their association with EF in a sample of people with type 2 diabetes.\u0000 \u0000 \u0000 \u0000 Adult members of a Medicaid health plan diagnosed with type 2 diabetes were enrolled in a social needs intervention trial. Using baseline data from the trial, bivariate and multivariable regression analyses examined associations between EF and demographic, health, and psychosocial factors.\u0000 \u0000 \u0000 \u0000 When controlling for other factors, we identified six significant correlates of EF impairment: age (β = 0.10), education (college vs. no college; β = −0.38), depression symptoms (β = 0.18), comorbidity burden (β = 0.21), diabetes-related distress (β = 0.14), and future time orientation (β = −0.13).\u0000 \u0000 \u0000 \u0000 Our analysis identified several factors associated with greater EF impairment, which may interfere with diabetes self-management. Providers should consider these factors when prescribing treatments and determine whether additional resources or accommodations are warranted.\u0000","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"36 47","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141659350","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Lisa T. Meade, Adriane B. Marino, Madison A. Barrier, Madison H. Wilson
The purpose of this study was to assess patient satisfaction and clinical experience with the t:slim X2 with Control-IQ Technology automated insulin delivery system. This descriptive study used a retrospective electronic health record review of all individuals trained on the Control-IQ system between December 2019 and April 2022 in one adult endocrinology practice. A total of 99 patients using the Control-IQ system for at least 3 months completed the glucose monitoring satisfaction survey (GMSS). The primary outcome was overall satisfaction with the system as measured by the GMSS. Secondary outcomes included changes in A1C from baseline at 3, 6, and 12 months, the association between GMSS scores and A1C levels, and the use of the system’s sleep activity feature to achieve lower A1C levels. The overall satisfaction score for patients using the system was 4.0 ± 0.6 (possible score range 1–5). A1C decreased by 0.6% 3 months, 0.7% at 6 months, and 0.8% at 12 months. Participants with A1C levels ≤7% did not experience greater satisfaction compared to those with higher A1C levels. Participants using the Control-IQ system reported a high rate of overall satisfaction and experienced significant reductions from baseline A1C at 3, 6, and 12 months.
{"title":"Patient Satisfaction and Clinical Experience With the Tandem t:slim X2 With Control-IQ Technology Advanced Hybrid Closed-Loop Insulin Delivery System","authors":"Lisa T. Meade, Adriane B. Marino, Madison A. Barrier, Madison H. Wilson","doi":"10.2337/ds23-0057","DOIUrl":"https://doi.org/10.2337/ds23-0057","url":null,"abstract":"\u0000 \u0000 The purpose of this study was to assess patient satisfaction and clinical experience with the t:slim X2 with Control-IQ Technology automated insulin delivery system.\u0000 \u0000 \u0000 \u0000 This descriptive study used a retrospective electronic health record review of all individuals trained on the Control-IQ system between December 2019 and April 2022 in one adult endocrinology practice. A total of 99 patients using the Control-IQ system for at least 3 months completed the glucose monitoring satisfaction survey (GMSS). The primary outcome was overall satisfaction with the system as measured by the GMSS. Secondary outcomes included changes in A1C from baseline at 3, 6, and 12 months, the association between GMSS scores and A1C levels, and the use of the system’s sleep activity feature to achieve lower A1C levels.\u0000 \u0000 \u0000 \u0000 The overall satisfaction score for patients using the system was 4.0 ± 0.6 (possible score range 1–5). A1C decreased by 0.6% 3 months, 0.7% at 6 months, and 0.8% at 12 months. Participants with A1C levels ≤7% did not experience greater satisfaction compared to those with higher A1C levels.\u0000 \u0000 \u0000 \u0000 Participants using the Control-IQ system reported a high rate of overall satisfaction and experienced significant reductions from baseline A1C at 3, 6, and 12 months.\u0000","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":" 16","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-07-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141675236","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}